SARS-CoV-2: a potential novel etiology of fulminant myocarditis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32140732)

Published in Herz on May 07, 2020

Authors

Chen Chen1, Yiwu Zhou2, Dao Wen Wang3

Author Affiliations

1: Division of Cardiology, Department of Internal Medicine, and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095# Jiefang Ave., 430030, Wuhan, China.
2: Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
3: Division of Cardiology, Department of Internal Medicine, and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095# Jiefang Ave., 430030, Wuhan, China. dwwang@tjh.tjmu.edu.cn.

Associated clinical trials:

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs (ACICOVID) | NCT04373759

Immunogenetics Predictors With COVID-19 | NCT04390269